NGL Fine-Chem Limited (NGLFINE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.056x

Based on the latest financial reports, NGL Fine-Chem Limited (NGLFINE) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs167.72 Million ≈ $1.81 Million USD) by net assets (Rs3.00 Billion ≈ $32.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NGL Fine-Chem Limited - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how NGL Fine-Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NGL Fine-Chem Limited debt and liabilities for a breakdown of total debt and financial obligations.

NGL Fine-Chem Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NGL Fine-Chem Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
IFGL Refractories Limited
NSE:IFGLEXPOR
0.007x
Igis Value Plus Reit Co Ltd
KO:334890
N/A
Indigo Acquisition Corp. Ordinary Shares
NASDAQ:INAC
0.265x
American Rare EARTHS Ltd
AU:ARR
-0.027x
LONCOR GOLD INC.
F:LO5
N/A
Centrum Medyczne ENEL-MED SA
WAR:ENE
0.146x
Areeya Property Public Company Limited
BK:A
-0.302x
Purit Co. Ltd.
KQ:445180
0.081x

Annual Cash Flow Conversion Efficiency for NGL Fine-Chem Limited (2009–2025)

The table below shows the annual cash flow conversion efficiency of NGL Fine-Chem Limited from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see market value of NGL Fine-Chem Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs2.82 Billion
≈ $30.54 Million
Rs358.22 Million
≈ $3.87 Million
0.127x +62.77%
2024-03-31 Rs2.63 Billion
≈ $28.40 Million
Rs204.65 Million
≈ $2.21 Million
0.078x -50.85%
2023-03-31 Rs2.23 Billion
≈ $24.07 Million
Rs352.86 Million
≈ $3.82 Million
0.159x +133.07%
2022-03-31 Rs2.03 Billion
≈ $21.98 Million
Rs138.25 Million
≈ $1.50 Million
0.068x -61.59%
2021-03-31 Rs1.54 Billion
≈ $16.70 Million
Rs273.54 Million
≈ $2.96 Million
0.177x -14.36%
2020-03-31 Rs989.61 Million
≈ $10.70 Million
Rs204.64 Million
≈ $2.21 Million
0.207x +115.34%
2019-03-31 Rs921.23 Million
≈ $9.96 Million
Rs88.47 Million
≈ $956.76K
0.096x -69.07%
2018-03-31 Rs720.42 Million
≈ $7.79 Million
Rs223.65 Million
≈ $2.42 Million
0.310x +84.86%
2017-03-31 Rs585.12 Million
≈ $6.33 Million
Rs98.26 Million
≈ $1.06 Million
0.168x -11.71%
2016-03-31 Rs442.15 Million
≈ $4.78 Million
Rs84.10 Million
≈ $909.54K
0.190x -16.82%
2015-03-31 Rs328.16 Million
≈ $3.55 Million
Rs75.04 Million
≈ $811.54K
0.229x +1990.49%
2014-03-31 Rs245.44 Million
≈ $2.65 Million
Rs-2.97 Million
≈ $-32.11K
-0.012x -932.61%
2013-03-31 Rs200.15 Million
≈ $2.16 Million
Rs-234.46K
≈ $-2.54K
-0.001x -101.43%
2012-03-31 Rs171.06 Million
≈ $1.85 Million
Rs14.01 Million
≈ $151.47K
0.082x -66.15%
2011-03-31 Rs160.59 Million
≈ $1.74 Million
Rs38.85 Million
≈ $420.12K
0.242x +140.92%
2010-03-31 Rs136.48 Million
≈ $1.48 Million
Rs13.70 Million
≈ $148.20K
0.100x +413.97%
2009-03-31 Rs109.35 Million
≈ $1.18 Million
Rs-3.50 Million
≈ $-37.82K
-0.032x --

About NGL Fine-Chem Limited

NSE:NGLFINE India Drug Manufacturers - General
Market Cap
$147.96 Million
Rs13.68 Billion INR
Market Cap Rank
#17699 Global
#919 in India
Share Price
Rs2214.50
Change (1 day)
-2.95%
52-Week Range
Rs995.00 - Rs2431.00
All Time High
Rs2712.46
About

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosph… Read more